Search
for
Sort by
Research 751–780 of 1000+
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- M2 Macrophage and Extracellular Matrix Genes Are Enriched in High‐Activity Lichen Planopilaris
- Elevated serum heat shock protein-70 and interleukin-15: prognostic biomarkers correlating with clinical severity and diagnostic efficacy in active alopecia areata
- Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Human adipose tissue–derived mesenchymal stromal cells and their phagocytic capacity
- The therapeutic efficacy of mesenchymal stem cells and their extracellular vesicles in the treatment of diverse skin diseases
- Chemokine C-C Motif Ligand 7 (CCL7), a Biomarker of Atherosclerosis, Is Associated with the Severity of Alopecia Areata: A Preliminary Study
- Update on pulse corticosteroid therapy for the management of alopecia areata
- Internal peacekeepers and external mediators: A new model of peripheral immune tolerance involving regulatory T cells and mesenchymal stem cells
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- Effects of microenvironment and biological behavior on the paracrine function of stem cells
- Multisystem Inflammatory Syndrome in Adults (MIS-A) and SARS-CoV2: An Evolving Relationship
- Isoxazole 9 (ISX9), a small molecule targeting Axin, activates Wnt/β‐catenin signalling and promotes hair regrowth
- Genetic Polymorphisms of Immunity Regulatory Genes and Alopecia Areata Susceptibility in Jordanian Patients
- Vaccines, adjuvants and autoimmunity
- The Genetics of Human Skin Disease
- Rice Bran Polysaccharides: Structure, Modification, Bioactivity, and Application Potential in Food and Health Systems
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- Efficacy of Dupilumab in Treating Atopic Dermatitis With Recurrent Eczema Herpeticum in a Patient With DOCK8-Deficiency Hyper-IgE Syndrome: A Case Report
- Drug Armamentarium for alopecia areata
- Platelet-derived bio-products: Classification update, applications, concerns and new perspectives
- Immune therapies for alopecia areata: evidence and new perspectives
- Role of DNA Methylation in the Pathogenesis of Skin Disorders: Mechanisms, Inhibitors of Methylation‐Related Enzyme, and Molecular Docking Studies
- Overview of Alopecia Areata
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Genetic analysis of interleukin 18 gene polymorphisms in alopecia areata